High triglycerides/low high-density lipoprotein cholesterol, ischemic electrocardiogram changes, and risk of ischemic heart disease

被引:27
作者
Jeppesen, J
Hein, HO
Suadicani, P
Gyntelberg, F
机构
[1] Copenhagen Univ Hosp, Epidemiol Res Unit, Copenhagen Male Study, DK-2400 Copenhagen NV, Denmark
[2] Glostrup Univ Hosp, Ctr Prevent Med, Glostrup, Denmark
关键词
D O I
10.1067/mhj.2003.45
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background High triglycerides (TG)/low high-density lipoprotein cholesterol (HDL-C)(TG greater than or equal to1.60 and HDL-C less than or equal to1.18 mmol/L) and ischemic ST-T changes in the resting electrocardiogram (ECG) are both strong risk factors of ischemic heart disease (IHD) in men without clinical cardiovascular diseases. This study tested the hypothesis that men free of clinic al IHD with high TG/low HDL-C and resting ischemic ECG changes would have a particularly poor prognosis with respect to IHD. Methods We conducted a cohort study of 2906 men, aged 53 to 74 years, without overt IHD at baseline. Results During 8 years, IHD developed in 229 men; 61 cases were fatal. Of the risk factors recorded, ischemic ECG, changes and high TG/low HDL-C were the strongest risk factors of IHD. Compared with men without high TG/low HDL-C and without ischemic ECG changes, age-adjusted relative risk of total IHD (95% Cl) was 3.5 (1.7-7.2) in men with both high TG/low HDL-C and ischemic ECG changes; the corresponding value for fatal IHD was 11.2 (4.9-25.8). Adjusted for conventional risk factors, the interaction term high TG/low HDL-C x ischemic ECG changes was a significant predictor of IHD death, with a relative risk of 2.6 (1.0-6.9). Conclusions In men free of clinical IHD, ischemic ECG changes were significantly more predictive of fatal IHD in men with high TG/low HDL-C, indicating an adverse synergistic effect of these 2 risk factors.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 37 条
[1]
BURSTEIN M, 1970, J LIPID RES, V11, P583
[2]
Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers [J].
Carantoni, M ;
Abbasi, F ;
Warmerdam, F ;
Klebanov, M ;
Wang, PW ;
Chen, YDI ;
Azhar, S ;
Reaven, GM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (05) :762-767
[3]
CASTELLI WP, 1992, AM J CARDIOL, V70, P3
[4]
Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women [J].
De Bacquer, D ;
De Backer, G ;
Kornitzer, M ;
Blackburn, H .
HEART, 1998, 80 (06) :570-577
[5]
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[6]
Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[7]
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]
INCREASED PLASMA-LEVELS OF A RAPID INHIBITOR OF TISSUE PLASMINOGEN-ACTIVATOR IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION [J].
HAMSTEN, A ;
WIMAN, B ;
DEFAIRE, U ;
BLOMBACK, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25) :1557-1563
[9]
HAMSTEN A, 1987, LANCET, V4, P3
[10]
ALCOHOL-CONSUMPTION, LEWIS PHENOTYPES, AND RISK OF ISCHEMIC-HEART-DISEASE [J].
HEIN, HO ;
SORENSEN, H ;
SUADICANI, P ;
GYNTELBERG, F .
LANCET, 1993, 341 (8842) :392-396